Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.
PRICE
Prev Close
0.14
Open
0.17
Day Range0.14 – 0.17
0.14
0.17
52W Range0.03 – 4.44
0.03
4.44
3% of range
50-Day MA
0.14(+0.0%)
200-Day MA
0.14(-0.0%)
VOLUME & SIZE
Avg Volume
9.6M
FUNDAMENTALS
P/E (TTM)
-0.1x
Not profitable
EPS (TTM)
—
Div Yield (TTM)
No dividend
Beta
1.69
High vol
TECHNICAL
RSI (14)
29
Oversold
OMGA News
About
Buy7 analysts
Target $9.00+6211.4%
omega therapeutics™ is a preclinical stage genomic medicine enterprise transforming medicine and patient care through precision genomic control. the company’s platform is focused on selectively directing the human genome to treat and cure disease by precisely controlling genomic expression without changing nucleic acid sequences. we are developing precision therapeutics for a range of disease indications including rare genetic diseases, immunology, inflammation, metabolic diseases and oncology. # transformativemedicines #pioneeringmedicines